Enveda

Enveda is a provider of an AI platform for drug discovery. From its funding announcement.

$311M Series ERaised yesterdayBoulder, USABiotech & PharmaUSA
Visit website →

In their own words

What Enveda says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "provider of an AI platform for drug discovery". Source

ProductResearch and development

Public signal Read from the company's own description of what the funding supports.

Why now

Where Enveda is today

Enveda announced a Series E round of $311M on 23 September 2026, led by Catalio Capital Management.

Latest round
Series E
Amount
$311M
Announced
23 September 2026
Headquarters
Boulder, USA
Sector
Biotech & Pharma
Growth stage
Series C+
Investors
Also participating
Relevant leadership
Founder and CEO Viswa Colluru

Momentum AfterRaise intelligence

AfterRaise Score

84
High momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
25/25
round size relative to the market
Funding stage
19/20
Series E
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 23 September 2026
    $311M Series E
    Led by Catalio Capital Management.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Product launches and new tiers
  • Product leadership hiring
  • Research programme expansion
  • Scientific team growth

Opportunities this could create

  • Clinical operations
  • Scientific hiring
  • Licensing and BD partnerships
  • Product leadership
  • Design partners

Based on the Biotech & Pharma sector, a Series C+ round and the priorities the company itself set out. Not a statement of fact.

Medium momentum3 connected signals
  • 23 September 2026$311M Series E announced
  • 23 September 2026Stated priority: product
  • 23 September 2026Stated priority: research and development

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Enveda is open to

Not yet specified

Enveda has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Enveda

All opportunities
OpportunityJOBPublic signal20 days ago
Enveda
Hyderabad

Director, ADME

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page
OpportunityJOBPublic signal45 days ago
Enveda
Hyderabad

Assoc. Director, Medicinal Chemistry

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page
OpportunityJOBPublic signal48 days ago
Enveda
Hyderabad

Research Associate, Invivo Pharmacology

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page
OpportunityJOBPublic signal48 days ago
Enveda
Hyderabad

Scientist, Invivo Pharmacology

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page
OpportunityJOBPublic signal48 days ago
Enveda
Hyderabad

Senior Principal Scientist, Medicinal Chemistry

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page
OpportunityJOBPublic signal4 months ago
Enveda
Hyderabad

Senior Research Associate, Invivo Pharmacology

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page
OpportunityJOBPublic signal11 months ago
Enveda
Hyderabad

Sr. Software Engineer, Lab Sciences

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page
OpportunityJOBPublic signal30 months ago
Enveda
Hyderabad

Asst. VP, Medicinal Chemistry

Enveda is hiring for this role on its own job board, after raising $311M.

Who they want
Approach preferences not yet specified
Apply on Enveda’s site →Company page

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Enveda?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Biotech & Pharma companies

See the sector